Friday, 20 March 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 20 March 2026
News

A dozen drugs hit listing limbo

 Posted 20 March 2026 PM

A dozen drugs that won a hard-earned tick from the PBAC at its November meeting have stalled in the PBS listing process, with our readers keen to learn which submissions have been marked inactive.

Some big names are on the list but so far the companies have not advised whether they intend to proceed, hinting at problems -with pricing usually the culprit. See which drugs are in limbo in: 12 drugs in PBS limbo pileup

To see the whole article, please login

Popular

Novo slapped with Warning Letter
'Bad juju' crashes Aussie company
World's top drug, by a loophole
A-list attends Sanofi office opening
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home